PTC Therapeutics | PTCT - الربح الإجمالي على المبيعات





الربح الإجمالي على المبيعات تغيير تاريخ
Acadia Pharmaceuticals USD 279.64M 36.37M 2026-06
Alnylam Pharmaceuticals USD 992.69M 167.68M 2026-06
Amgen USD 5.87B 1.02B 2026-03
BioCryst Pharmaceuticals USD 214.41M 61.36M 2026-06
Biogen USD 2.12B 307M 2026-06
BioMarin Pharmaceutical USD 713.42M 142.21M 2026-06
Cytokinetics USD 23.03M 3.84M 2026-06
Daiichi Sankyo JPY 287.15B 152.68B 2026-03
Enanta Pharmaceuticals -22.29M 23.75M 2024-12
Gilead Sciences USD 6.8B 1.29B 2026-06
Incyte USD 1.57B 400.89M 2026-06
Ionis Pharmaceuticals USD 265M 22M 2026-06
Ironwood Pharmaceuticals USD 85.24M 44.1M 2025-06
Karyopharm Therapeutics USD 33.72M 1.13M 2026-03
Novartis USD 11.24B 1.18B 2026-06
Pfizer USD -248M 11.29B 2026-06
PTC Therapeutics USD 232.94M 84.56M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Roche Holding CHF 22.69B 600M 2026-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Sarepta Therapeutics USD 251.15M 370.2M 2026-06
TG Therapeutics USD 199.14M 27.73M 2026-06
Ultragenyx Pharmaceutical USD 180M 74M 2026-06
Vertex Pharmaceuticals USD 2.84B 242.4M 2026-06
Xencor USD 51.22M 46.7M 2026-06